Sort   by:  
 Page size 
GenomicsSingle cell RNA-seq analysis of endothelial cells (HUVEC) treated with IL1b and TGFb2 as a model of endothelial to mesenchymal transition (EndMT)
Single cell RNA-seq analysis of endothelial cells (HUVEC) treated with IL1b and TGFb2 as a model of endothelial to mesenchymal transition (EndMT)
PRJNA670667 | ENA
ProteomicsIntegration of functional imaging, cytometry and unbiased proteomics reveals new features of endothelial-to-mesenchymal transition in ischemic mitral valve regurgitation in human patients
Background: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to isch...
ORGANISM(S): Homo sapiens (Human) 
2021-08-13 | PXD025096 | Pride
Human Mitral valve (mv) Proteomic Ischemic mitral regurgitation (imr) Echocardiography Endothelial-to-mesenchymal transition (endmt) Histo-cytometry 
ProteomicsSecretomes from non-small cell lung cancer cells induce endothelial plasticity through a partial endothelial-to-mesenchymal transition
The tumor microenvironment (TME) of non-small cell lung cancer (NSCLC) is highly heterogeneous and is involved in tumorigenesis and resistance to therapy. Among the cells of the TME, endothelial cells are associated with the latter processes through endothelial-to-mesenchymal transition (EndMT). Dur...
ORGANISM(S): Homo sapiens (Human) 
2025-04-24 | PXD054295 | Pride
Human Emt Dia-pasef Non-small cell Lung cancer Secretome 
GenomicsLARP7 suppresses endothelial-to-mesenchymal transition by coupling with TRIM28
LARP7 suppresses endothelial-to-mesenchymal transition by coupling with TRIM28
PRJNA694430 | ENA
GenomicsTranscriptome changes during Endothelial to Mesenchymal Transition (EndMT) using a TGF-b2 and IL-1b in vitro model of EndMT in HUVEC and HPAEC
Transcriptome changes during Endothelial to Mesenchymal Transition (EndMT) using a TGF-b2 and IL-1b in vitro model of EndMT in HUVEC and HPAEC
PRJNA485688 | ENA
GenomicsThe histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition [microarray]
The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition [microarray]
PRJNA599505 | ENA
GenomicsThe histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition [HTS]
The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition [HTS]
PRJNA599372 | ENA
UnknownLocal and Circulating Endothelial Cells Undergo Endothelial to Mesenchymal Transition (EndMT) in Response to Musculoskeletal Injury.
Not available
S-EPMC5018841 | biostudies-literature
GenomicsLong non-coding RNA MIR503HG controls endothelial-to-mesenchymal transition
Long non-coding RNA MIR503HG controls endothelial-to-mesenchymal transition
PRJNA486849 | ENA
TranscriptomicsSingle cell RNA-seq analysis of endothelial cells (HUVEC) treated with IL1b and TGFb2 as a model of endothelial to mesenchymal transition (EndMT)
Endothelial-to-mesenchymal transition (EndMT) is a dynamic biological process involved in pathological vascular remodeling. However, the molecular mechanisms that govern this transition remain largely unknown. To study EndMT in vitro, human umbilical vein endothelial cells (HUVEC) were treated with ...
ORGANISM(S): Homo sapiens 
2021-04-06 | GSE159843 | GEO
Sort   by:  
 Page size